Practice Points

COVID-19 PREP Act Declarations and EUAs for Medical Device Licensors

By James R. Browning Jr. – June 29, 2020 | Practitioners should review the relevant PREP Act declarations and FDA EUAs before and in advising clients who may be considering licenses giving free access to their intellectual property.

For Effective Written Advocacy, Remember to Properly Frame Your Issue

By W. Clay Massey – June 2, 2020 | What is it you need the court to focus on in order to prevail and how should you define that issue in a way that will help the court maintain that focus?

Read More - Practice Points


If at First You Don’t Succeed: Prospects for a Second Removal after Remand

By Monee Hanna and Dustin Rawlin – April 7, 2020 | Fighting for removal, even in the face of a remand order, can often result in a second chance in federal court.

The Top Five Drug and Device Developments of 2019

By Hannah Anderson, Isabelle Chammas, Christine Kain, and Patrick Reilly – January 16, 2020 | A “negotiation class,” plaintiffs’ legal ads, vaping, multidistrict litigation reform, and Daubert gatekeeping.

Read More - Articles


COVID Exposure Claims Post-Reopening

By Paul V. Majkowski – April 30, 2020 | In this Sound Advice, Paul Majkowski explores aspects of potential tort claims for COVID exposure occurring after reopening from stay-at-home orders. (9:04 min)

Top 3 Lessons Learned From Litigating Spanish Flu Cases

By Sarah Frederick – April 29, 2020 | In this Sound Advice, drug and device litigation partner Sarah Frederick from Goodwin Procter discusses lessons gleaned from medical malpractice, products liability, legal malpractice, and business litigation cases that arose out of the Spanish Influenza pandemic of 1918 and 1919, and how they may help attorneys and their clients as they navigate the current COVID-19 pandemic. (8:22 min)

Listen to More - Audio

Mass Torts Litigation

Learn how to get involved with the Mass Torts committee and maximize your Section membership!